Mylan N.V. (MYL) Shares Bought by Commonwealth Bank of Australia

Commonwealth Bank of Australia raised its stake in shares of Mylan N.V. (NASDAQ:MYL) by 6.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 46,106 shares of the company’s stock after purchasing an additional 2,789 shares during the period. Commonwealth Bank of Australia’s holdings in Mylan were worth $1,439,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the stock. Bellwether Investment Group LLC increased its position in Mylan by 0.3% during the second quarter. Bellwether Investment Group LLC now owns 6,622 shares of the company’s stock worth $257,000 after purchasing an additional 23 shares during the last quarter. Suntrust Banks Inc. increased its position in shares of Mylan by 0.7% in the second quarter. Suntrust Banks Inc. now owns 9,184 shares of the company’s stock worth $355,000 after acquiring an additional 60 shares in the last quarter. Dai Ichi Life Insurance Company Ltd increased its position in shares of Mylan by 0.4% in the second quarter. Dai Ichi Life Insurance Company Ltd now owns 26,002 shares of the company’s stock worth $1,009,000 after acquiring an additional 107 shares in the last quarter. Wealthsource Partners LLC increased its position in shares of Mylan by 1.9% in the second quarter. Wealthsource Partners LLC now owns 9,330 shares of the company’s stock worth $362,000 after acquiring an additional 177 shares in the last quarter. Finally, Accident Compensation Corp increased its position in shares of Mylan by 0.3% in the second quarter. Accident Compensation Corp now owns 71,035 shares of the company’s stock worth $2,758,000 after acquiring an additional 200 shares in the last quarter. 73.86% of the stock is owned by hedge funds and other institutional investors.

Mylan N.V. (NASDAQ:MYL) opened at $37.44 on Tuesday. Mylan N.V. has a 52 week low of $29.39 and a 52 week high of $45.87. The company has a quick ratio of 0.95, a current ratio of 1.46 and a debt-to-equity ratio of 1.05. The firm has a market cap of $20,448.95, a price-to-earnings ratio of 8.11, a PEG ratio of 2.09 and a beta of 1.38.

Mylan (NASDAQ:MYL) last posted its quarterly earnings data on Monday, November 6th. The company reported $1.10 EPS for the quarter, missing the Zacks’ consensus estimate of $1.20 by ($0.10). Mylan had a net margin of 7.28% and a return on equity of 20.63%. The company had revenue of $2.99 billion for the quarter, compared to the consensus estimate of $3.09 billion. During the same quarter last year, the company earned $1.38 earnings per share. The company’s revenue was down 2.3% compared to the same quarter last year. analysts anticipate that Mylan N.V. will post 4.56 EPS for the current fiscal year.

Several research firms have recently issued reports on MYL. Cowen reissued a “hold” rating and issued a $30.00 price objective (down previously from $43.00) on shares of Mylan in a research report on Wednesday, August 9th. Cantor Fitzgerald set a $34.00 price objective on shares of Mylan and gave the stock a “hold” rating in a research report on Wednesday, August 9th. Wells Fargo & Company set a $30.00 price objective on shares of Mylan and gave the stock a “hold” rating in a research report on Wednesday, August 9th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $32.00 price objective (down previously from $33.00) on shares of Mylan in a research report on Thursday, August 10th. Finally, BMO Capital Markets reissued an “outperform” rating and issued a $45.00 price objective (down previously from $50.00) on shares of Mylan in a research report on Thursday, August 10th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and thirteen have given a buy rating to the company. Mylan currently has an average rating of “Buy” and an average target price of $41.49.

TRADEMARK VIOLATION WARNING: This piece was published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.chaffeybreeze.com/2017/12/05/mylan-n-v-myl-shares-bought-by-commonwealth-bank-of-australia.html.

About Mylan

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Institutional Ownership by Quarter for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply